Partial
Partially Aligned
Patient Risk:
Medium
Summary
Partially aligned with the provided FDA label excerpt: cardiovascular risk-reduction indication language is consistent, but there is a direct contradiction/overreach regarding pancreatitis risk. Most other claims relate to coupon/discount services and are not label-supported (appropriately marked absent), though the label-based evaluation scope is limited to Indications and Usage.
Category Scores
Accurate Statements
Vascepa is used to reduce the risk of cardiovascular events (such as heart attack and stroke) in patients with high triglycerides and established cardiovascular disease.
1 INDICATIONS AND USAGE: adjunct to maximally tolerated statin therapy in adult patients with elevated triglyceride levels (≥150 mg/dL) and established cardiovascular disease to reduce risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization.
Unsupported Statements
Vascepa (icosapent ethyl) is a prescription medication.
The provided label excerpt does not explicitly state 'prescription-only' status; it only identifies the product in the indications section.
Vascepa is used to treat high triglycerides.
Label support is conditional (adult patients with elevated TG levels in specific contexts for cardiovascular risk reduction and/or severe hypertriglyceridemia to reduce TG levels). The statement is broader than the label excerpt.
GoodRx offers Vascepa coupon codes and discounts.
No coupon/discount information is present in the provided label excerpt.
The GoodRx website allows patients to search for medication and find discounts and coupons usable at their local pharmacy.
No GoodRx website/functionality or discount-card/coupon claims are present in the provided label excerpt.
GoodRx offers a discount card that can be used to save up to 80% on Vascepa and other medications.
No discount-card percentage or availability claims are present in the provided label excerpt.
RxSaver offers Vascepa coupon codes and discounts.
No coupon/discount information is present in the provided label excerpt.
The RxSaver website allows patients to search for medication and find discounts and coupons usable at their local pharmacy.
No RxSaver website/functionality claims are present in the provided label excerpt.
RxSaver offers a discount card that can be used to save up to 75% on Vascepa and other medications.
No discount-card percentage or availability claims are present in the provided label excerpt.
Discount Drug Network offers Vascepa coupon codes and discounts.
No coupon/discount information is present in the provided label excerpt.
The Discount Drug Network website allows patients to search for medication and find discounts and coupons usable at their local pharmacy.
No Discount Drug Network website/functionality claims are present in the provided label excerpt.
Discount Drug Network offers a discount card that can be used to save up to 75% on Vascepa and other medications.
No discount-card percentage or availability claims are present in the provided label excerpt.
CardBenefit offers Vascepa coupon codes and discounts.
No coupon/discount information is present in the provided label excerpt.
The CardBenefit website allows patients to search for medication and find discounts and coupons usable at their local pharmacy.
No CardBenefit website/functionality claims are present in the provided label excerpt.
CardBenefit offers a discount card that can be used to save up to 75% on Vascepa and other medications.
No discount-card percentage or availability claims are present in the provided label excerpt.
DrugPatentWatch.com provides information on patent expiration dates for medications, including Vascepa.
No patent-expiration information or references are present in the provided label excerpt.
DrugPatentWatch.com offers Vascepa coupon codes and discounts.
No coupon/discount information is present in the provided label excerpt.
According to DrugPatentWatch.com, Vascepa's patent is set to expire in 2024.
No patent status/expiration information is present in the provided label excerpt.
Vascepa coupon codes may only be accepted at certain pharmacies.
No coupon acceptance rules are present in the provided label excerpt.
Most Vascepa coupon codes can only be used once.
No coupon usage-limit rules are present in the provided label excerpt.
Vascepa coupon codes may be available through mail-in rebates or in-store promotions.
No coupon delivery/fulfillment mechanisms are present in the provided label excerpt.
Vascepa coupon codes can be used in addition to insurance coverage.
No statements about coupon/insurance stacking are present in the provided label excerpt.
Contradictions
High
AI Statement
Vascepa is prescribed to patients who have high triglycerides and are at risk of developing pancreatitis.
Label Reference
1 INDICATIONS AND USAGE: Limitation of Use — "The effect of VASCEPA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined."
Important Omissions
No evaluation against FDA labeling content outside the provided '1 INDICATIONS AND USAGE' excerpt (e.g., contraindications, boxed warnings, warnings/precautions, dosage and administration, drug interactions, adverse reactions, and specific populations).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
A direct labeling limitation was contradicted by framing Vascepa as being prescribed to reduce pancreatitis risk. Other claims are non-label discount/marketing assertions and do not reflect FDA safety content, but the pancreatitis-related contradiction is label-relevant.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Partially Aligned
Primary Issue
Contradiction/overreach regarding pancreatitis risk despite the label stating the pancreatitis risk effect has not been determined.
Suggested Improvement
Remove or rephrase pancreatitis-risk claims and align indication language strictly with the label indications and limitations (e.g., avoid asserting pancreatitis risk reduction; instead reflect that the effect on pancreatitis risk has not been determined).